Novartis AG entered into a definitive agreement to acquire Pikavation Therapeutics, Inc. from Synnovation Therapeutics, Inc. for $3 billion.
Novartis→Pikavation Therapeutics
Mar 20, 2026
Tracking 670 merger M&A deals. Browse merger transactions across all sectors and states.
Novartis→Pikavation Therapeutics
Mar 20, 2026
IonQ→SkyWater Technology
Mar 20, 2026
Stock Yards Bancorp→Field & Main Bancorp
Mar 20, 2026
Embecta→Owen Mumford Holdings
Mar 20, 2026
3M→Madison Fire & Rescue
Mar 19, 2026
Collegium Pharmaceutical→Corium Therapeutics
Mar 19, 2026
Danaher→Masimo
Mar 18, 2026
Mission Produce→Calavo Growers
Mar 18, 2026
Independent Bank→HCB Financial
Mar 18, 2026
Kinderhook Industries→Enhabit Home Health & Hospice
Mar 17, 2026
IBM→Confluent
Mar 17, 2026
Public Storage→National Storage Affiliates Trust
Mar 17, 2026
Sumitomo Forestry→Tri Pointe Homes
Mar 17, 2026
Victory Capital→Janus Henderson
Mar 17, 2026
Royal Cup→Farmer Bros
Mar 17, 2026
UniCredit→Commerzbank
Mar 16, 2026
Brookfield→Peakstone Realty Trust
Mar 16, 2026
Generac→Enercon
Mar 13, 2026
Barinthus Biotherapeutics→Clywedog Therapeutics
Mar 13, 2026
Signature Bancorp→Esquire Financial Holdings
Mar 12, 2026